Inventiva (IVEVF) Assets Average (2019 - 2025)
Inventiva (IVEVF) posted Assets Average of $246.5 million for Q4 2025, up 49.53% on a QoQ basis from $164.8 million in Q2 2025, and up 233.48% year-over-year from $73.9 million in Q4 2024.
Analysis
Inventiva (IVEVF) Assets Average (2019 - 2025) Analysis & Trends
Inventiva has reported Assets Average for 7 years, with the latest figure at $246.5 million in Q4 2025.
- On a quarterly basis, Assets Average rose 233.48% year-over-year to $246.5 million in Q4 2025; TTM through Dec 2025 was $246.5 million, a 233.48% increase from a year earlier, with the FY2025 full-year figure at $208.8 million, up 106.75% from the prior year.
- Assets Average was $246.5 million for Q4 2025 at Inventiva, up from $164.8 million in the prior quarter.
- The five-year high for Assets Average was $246.5 million in Q4 2025, with the low at $47.8 million in Q2 2024.
- Average Assets Average over 5 years is $128.8 million, with a median of $134.0 million recorded in 2021.
- The sharpest annual moves came in 2024 and 2025: Assets Average tumbled 51.11% in 2024, then soared 245.03% in 2025.
- Over 5 years, Assets Average stood at $140.4 million in 2021, then dropped by 9.08% to $127.6 million in 2022, then tumbled by 40.46% to $76.0 million in 2023, then fell by 2.71% to $73.9 million in 2024, then surged by 233.48% to $246.5 million in 2025.
- The last three Assets Average figures came in at $246.5 million (Q4 2025), $164.8 million (Q2 2025), and $73.9 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn | 200.98 Bn |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn | 135.79 Bn |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn | 129.24 Bn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | 120.28 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 204.57 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 149.95 Bn |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - | 3.29 Bn |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn | 7.61 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 6.97 Bn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | 246.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 246.51 Mn |
| Jun 30, 2025 | 164.85 Mn |
| Dec 31, 2024 | 73.92 Mn |
| Jun 30, 2024 | 47.78 Mn |
| Dec 31, 2023 | 75.98 Mn |
| Jun 30, 2023 | 97.73 Mn |
| Jun 30, 2022 | 127.60 Mn |
| Dec 31, 2021 | 140.35 Mn |
| Jun 30, 2021 | 150.32 Mn |
| Mar 31, 2021 | 162.56 Mn |
| Dec 31, 2020 | 120.66 Mn |
| Dec 31, 2019 | 77.07 Mn |